Quizartinib is an FLT3 inhibitor, used for people with relapsed or tough cases of acute myeloid leukemia, specifically those with FLT3-ITD mutations. It works by stopping FLT3 from sending those signals it does. You can find the drug in two strengths – 17.7 mg and 26.5 mg in these coated pills.
You’re supposed to start with 53 mg of quizartinib, taken once a day, and it’s like a slowly increasing process. Each bottle packs 28 tablets for your quizartinib.